A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer.
作者:
主题词
腺癌(Adenocarcinoma);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);临床试验(主题)(Clinical Trials as Topic);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);女(雌)性(Female);氟尿嘧啶(Fluorouracil);人类(Humans);美法仑(Melphalan);甲氨蝶呤(Methotrexate);中年人(Middle Aged);卵巢肿瘤(Ovarian Neoplasms);前瞻性研究(Prospective Studies);随机分配(Random Allocation);噻替派(Thiotepa)
DOI
10.1002/1097-0142(19850101)55:1<26::aid-cncr2820550105>3.0.co;2-d
PMID
3917352
发布时间
2019-06-19
- 浏览17

Cancer
26-40页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文